IS SARM - Selective Androgen Receptor Modulator: A Chance for Therapeutic Approach in Muscle-Wasting Chronic Conditions?

被引:1
作者
Bartoli, Alessandro [1 ,2 ]
Maffulli, Nicola [3 ,4 ,5 ]
Oliva, Gabriella [6 ]
Ziello, Salvatore [1 ,2 ]
Oliva, Francesco [7 ]
机构
[1] Univ Salerno, Fac Med & Surg, Dept Musculoskeletal Disorders, Baronissi, Italy
[2] San Giovanni di Dio & Ruggi Aragona Hosp, Orthoped Clin, Salerno, Italy
[3] Queen Mary Univ London, Barts & London Sch Med & Dent, Ctr Sports & Exercise Med, Mile End Hosp, London, England
[4] Keele Univ, Fac Med, Sch Pharm & Bioengn, Guy Hilton Res Ctr, Stoke on Trent, England
[5] Univ Roma La Sapienza, Fac Med & Psychol, Dept Trauma & Orthopaed Surg, Rome, Italy
[6] Osped Mare ASL NA1 Ctr, Dept Internal Med, Naples, Italy
[7] San Raffaele Roma Open Univ, Dept Human Sci & Promot Qual Life, via di Val Cannuta 247, Rome, Italy
来源
MLTJ-MUSCLES LIGAMENTS AND TENDONS JOURNAL | 2024年 / 14卷 / 02期
关键词
SARM; SERM; muscle-wasting; cachexia; sarcopenia; PREVENTS BONE LOSS; DOUBLE-BLIND; PHYSICAL FUNCTION; ENOBOSARM; CACHEXIA; CANCER; DISCOVERY; EXERCISE; GTX-024; POTENT;
D O I
10.32098/mltj.02.2024.17
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Purpose of review. The purpose of this paper is to review the current concepts regarding a new-old pharmacological class, SARM (Selective Androgen Receptor Modulator). Especially how SARM can be beneficial in treatment of orthopedic disease. Materials and methods. Androgens (testosterone and dihydrotestosterone (DHT)) are the male sex hormones required for development of the male reproductive system and secondary sexual characteristics. SARMs due to ability to bind androgen receptor are excellent in treatment of various diseases. Discussion. Based on the published literature, a review has been carried out on SARM and its fields of application in the treatment of muscle wasting pathologies. Starting from the history of the SARMs, its role in prevention of muscle wasting, anabolic effects and side effects were addressed. Conclusions. Nonsteroidal SARMs are unique in their ability to bind the androgen receptor with high affinity and exhibit tissue selective activity. SARMs can be used to treat muscle wasting conditions, osteoporosis, frailty syndrome without unwanted side effects associated with androgens.
引用
收藏
页码:361 / 366
页数:6
相关论文
共 38 条
[1]   Muscle wasting disease: a proposal for a new disease classification [J].
Anker, Stefan D. ;
Coats, Andrew J. S. ;
Morley, John E. ;
Rosano, Giuseppe ;
Bernabei, Roberto ;
von Haehling, Stephan ;
Kalantar-Zadeh, Kamyar .
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2014, 5 (01) :1-3
[2]   Cachexia and sarcopenia: mechanisms and potential targets for intervention [J].
Argiles, Josep M. ;
Busquets, Silvia ;
Stemmler, Britta ;
Lopez-Soriano, Francisco J. .
CURRENT OPINION IN PHARMACOLOGY, 2015, 22 :100-106
[3]   Pharmacological options for advanced cancer patients with loss of appetite and weight [J].
Behl, Deepti ;
Jatoi, Aminah .
EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (08) :1085-1090
[4]   Discovery and therapeutic promise of selective androgen receptor modulators [J].
Chen, JY ;
Kim, J ;
Dalton, JT .
MOLECULAR INTERVENTIONS, 2005, 5 (03) :173-188
[5]   Study Design and Rationale for the Phase 3 Clinical Development Program of Enobosarm, a Selective Androgen Receptor Modulator, for the Prevention and Treatment of Muscle Wasting in Cancer Patients (POWER Trials) [J].
Crawford, Jeffrey ;
Prado, Carla M. M. ;
Johnston, Mary Ann ;
Gralla, Richard J. ;
Taylor, Ryan P. ;
Hancock, Michael L. ;
Dalton, James T. .
CURRENT ONCOLOGY REPORTS, 2016, 18 (06)
[6]   The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial [J].
Dalton, James T. ;
Barnette, Kester G. ;
Bohl, Casey E. ;
Hancock, Michael L. ;
Rodriguez, Domingo ;
Dodson, Shontelle T. ;
Morton, Ronald A. ;
Steiner, Mitchell S. .
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2011, 2 (03) :153-161
[7]  
Davey Rachel A, 2016, Clin Biochem Rev, V37, P3
[8]   Pathogenesis and Management of Sarcopenia [J].
Dhillon, Robinder J. S. ;
Hasni, Sarfaraz .
CLINICS IN GERIATRIC MEDICINE, 2017, 33 (01) :17-+
[9]   Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial [J].
Dobs, Adrian S. ;
Boccia, Ralph V. ;
Croot, Christopher C. ;
Gabrail, Nashat Y. ;
Dalton, James T. ;
Hancock, Michael L. ;
Johnston, Mary A. ;
Steiner, Mitchell S. .
LANCET ONCOLOGY, 2013, 14 (04) :335-345
[10]   Muscle wasting in ageing and chronic illness [J].
Ebner, Nicole ;
Sliziuk, Veronika ;
Scherbakov, Nadja ;
Sandek, Anja .
ESC HEART FAILURE, 2015, 2 (02) :58-68